S. Wu

发表

A systematic review of combination therapy with stimulants and atomoxetine for attention-deficit/hyperactivity disorder, including patient characteristics, treatment strategies, effectiveness, and tolerability.

T. Treuer, S. Gau, J. A. Monk, 2013, Journal of child and adolescent psychopharmacology.

Factors affecting treatment adherence to atomoxetine in ADHD: a systematic review

T. Treuer, W. Montgomery, Luis Méndez, 2016, Neuropsychiatric disease and treatment.

Patient characteristics associated with treatment initiation among paediatric patients with Attention-Deficit/Hyperactivity Disorder symptoms in a naturalistic setting in

J. Haro, T. Treuer, W. Montgomery, 2014 .

Predictors of pharmacological treatment outcomes with atomoxetine or methylphenidate in patients with attention‐deficit/hyperactivity disorder from China, Egypt, Lebanon, Russian Federation, Taiwan, and United Arab Emirates

T. Treuer, M. Altın, D. Desaiah, 2014, International journal of clinical practice.

Neuropsychiatric Disease and Treatment Dovepress Dovepress

Gang Wang, H. Xue, S. Wu, 2022 .

Exploratory analysis of early treatment discontinuation and clinical outcomes of patients with attention‐deficit/hyperactivity disorder

T. Treuer, Ke Wang, Yun Chen, 2017, Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists.

Patient characteristics associated with treatment initiation among paediatric patients with Attention-Deficit/Hyperactivity Disorder symptoms in a naturalistic setting in Central Europe and East Asia

J. Haro, T. Treuer, W. Montgomery, 2014, BMC Psychiatry.

Predictors and consequences of adherence to the treatment of pediatric patients with attention-deficit/hyperactivity disorder in Central Europe and East Asia

J. Haro, T. Treuer, W. Montgomery, 2013, Patient preference and adherence.

Differential Response Profiles in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

L. Wietecha, K. Saylor, D. Kelsey, 2015, Clinical pediatrics.

Does participation in a weight control program also improve clinical and functional outcomes for Chinese patients with schizophrenia treated with olanzapine?

T. Treuer, H. Ascher-Svanum, Z. Kadziola, 2014, Neuropsychiatric disease and treatment.

Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Chinese subpopulation analysis of a double-blind, randomized, placebo-controlled study

Gang Wang, H. Xue, S. Wu, 2016, Neuropsychiatric disease and treatment.